PEAK6 Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,002
Closed -$276K 3797
2024
Q1
$276K Sell
4,002
-2,993
-43% -$189K ﹤0.01% 2852
2023
Q4
$517K Buy
6,995
+4,946
+241% +$324K ﹤0.01% 2584
2023
Q3
$140K Buy
+2,049
New +$174K ﹤0.01% 3255
2022
Q1
Sell
-43,532
Closed -$3.18M 5411
2021
Q4
$3.39M Sell
43,532
-8,402
-16% -$742K 0.01% 1443
2021
Q3
$4.96M Buy
51,934
+214
+0.4% +$22.6K 0.01% 1166
2021
Q2
$6.43M Sell
51,720
-13,136
-20% -$1.57M 0.02% 927
2021
Q1
$8.55M Buy
+64,856
New +$8.88M 0.02% 725
2020
Q3
Sell
-47,543
Closed -$4.11M 4525
2020
Q2
$4.13M Sell
47,543
-110,015
-70% -$8.79M 0.01% 930
2020
Q1
$9.14M Buy
157,558
+74,750
+90% +$6.07M 0.05% 333
2019
Q4
$7.66M Buy
82,808
+21,385
+35% +$1.88M 0.04% 449
2019
Q3
$5.55M Buy
+61,423
New +$7M 0.03% 622
2019
Q2
Sell
-33,827
Closed -$3.41M 3845
2019
Q1
$2.93M Buy
+33,827
New +$2.88M 0.02% 1038
2018
Q4
Sell
-7,606
Closed -$522K 4197
2018
Q3
$600K Buy
+7,606
New +$496K ﹤0.01% 2408

Other funds holding EXAS

PEAK6 Investments's EXAS Position: Q2 2024 in Review

PEAK6 Investments sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 4,002 shares — an estimated $276K sold.

PEAK6 Investments first reported a position in EXAS in Q3 2018 and held it in 13 quarters. The position peaked at $9.14M in Q1 2020. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • PEAK6 Investments reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 4,002 Exact Sciences shares in Q2 2024, an estimated $276K.
  • PEAK6 Investments first reported a position in Exact Sciences in Q3 2018 and held it in 13 quarters.
  • PEAK6 Investments's Exact Sciences position peaked at $9.14M in Q1 2020.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.